Evidence map›Paper›PMID 33580145›Full record

ArticleScientific reports2021

Mechanism of karyopherin-β2 binding and nuclear import of ALS variants FUS(P525L) and FUS(R495X).

Abner Gonzalez, Taro Mannen, Tolga Çağatay, Ayano Fujiwara, Hiroyoshi Matsumura, Ashley B Niesman, Chad A Brautigam, Yuh Min Chook, Takuya Yoshizawa

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Small molecule JRMS modulating importin-β1 chaperone activity as a therapeutic strategy reducing TDP-43 pathology.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Karyopherin-mediated nucleocytoplasmic transport.Nature reviews. Molecular cell biology · 2022
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Abner GonzalezDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Taro MannenCollege of Life Sciences, Ritsumeikan University, Shiga, Japan.
Tolga ÇağatayDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ayano FujiwaraCollege of Life Sciences, Ritsumeikan University, Shiga, Japan.
Hiroyoshi MatsumuraCollege of Life Sciences, Ritsumeikan University, Shiga, Japan.
Ashley B NiesmanDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Chad A BrautigamDepartment of Biophysics, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Yuh Min ChookDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA. yuhmin.chook@utsouthwestern.edu.
Takuya YoshizawaCollege of Life Sciences, Ritsumeikan University, Shiga, Japan. t-yosh@fc.ritsumei.ac.jp.
The University of Texas Southwestern Medical Center · USRitsumeikan University · JP

Funding

TR&D Project 4. The Imaging Stage: Multiscale Spatiotemporal Modeling of Macromolecular Systems in Cellular NeighborhoodsP41GM109824 · NIGMS · ROCKEFELLER UNIVERSITY · PI ROUT, MICHAEL P · 2014 to 2023
$18.8M
Structures and Mechanisms of Nuclear Import and ExportR01GM069909 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI CHOOK, YUH MIN · 2004 to 2020
$5.8M
Biochemical and cellular functions of Karyopherins - Revision - 2R35GM141461 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI Yuh Min Chook · 2021 to 2026
$2.8M
Kapβ2 recognition of cargos involved in neurodegenerative/neurodevelopmental diseasesF31NS120465 · NINDS · UT SOUTHWESTERN MEDICAL CENTER · PI GONZALEZ-CASTRO, ABNER · 2020 to 2021
$79k
NIGMS NIH HHS P41 GM109824NIGMS NIH HHS R01 GM069909NIGMS NIH HHS R35 GM141461NINDS NIH HHS F31 NS120465
6 · The paper itself

Abstract

Mutations in the RNA-binding protein FUS cause familial amyotropic lateral sclerosis (ALS). Several mutations that affect the proline-tyrosine nuclear localization signal (PY-NLS) of FUS cause severe juvenile ALS. FUS also undergoes liquid-liquid phase separation (LLPS) to accumulate in stress granules when cells are stressed. In unstressed cells, wild type FUS resides predominantly in the nucleus as it is imported by the importin Karyopherin-β2 (Kapβ2), which binds with high affinity to the C-terminal PY-NLS of FUS. Here, we analyze the interactions between two ALS-related variants FUS(P525L) and FUS(R495X) with importins, especially Kapβ2, since they are still partially localized to the nucleus despite their defective/missing PY-NLSs. The crystal structure of the Kapβ2·FUS(P525L)

Indexed as

Active Transport, Cell NucleusAmyotrophic Lateral Sclerosisbeta KaryopherinsBinding SitesCell NucleusHumansKaryopherinsNuclear Localization SignalsProtein BindingRNA-Binding Protein FUSbeta KaryopherinsFUS protein, humanKaryopherinsNuclear Localization SignalsRNA-Binding Protein FUSTNPO1 protein, human

Identifiers

PMID33580145
PMCPMC7881136
OpenAlexW3128391638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.